-
The safer sex message is reaching adolescents. Results of a new Centers for Disease Control and Prevention (CDC) report shows the percentage of teen males ages 15-19 in the United States who used a condom the first time they had sex increased between 2002 and 2006-2010.
-
The contraceptive options for women who cannot use hormonal methods might soon expand if regulatory approval is given to a new single-size diaphragm. Results of a two-year multi-site study of 450 U.S. couples indicate the effectiveness rates of the SILCS single size, contoured diaphragm, now in development, are similar to traditional diaphragms.
-
To perform the study, researchers designed a pooled analysis of individual data from two large studies by the International Agency for Research on Cancer, an international collaboration on cancer research, and the Institut Català d'Oncologia, a Spanish-based oncology research program.
-
While intrauterine devices (IUDs) represent a safe, effective, and reversible form of birth control, results of a new study indicate many U.S. women choose sterilization immediately postpartum.
-
Check your pharmacy stock, and review patient pill choices: A nationwide recall of multiple lots of Qualitest oral contraceptives (OCs) has been issued after the Huntsville, AL-based manufacturer detected a packaging error that could lead to incorrect administration of pills.
-
How can your clinic reach more women at risk for chlamydia and gonorrhea? Take a tip from the Sexually Transmitted Disease (STD) Program at the Los Angeles County Department of Public Health, which is expanding its popular "I Know" at-home testing program in a further outreach to the community.
-
The objective of the Endometriosis: Natural History, Diagnosis, and Outcomes (ENDO) study funded by the National Institute of Child Health and Human Development was to estimate the incidence of endometriosis.
-
A 70-year-old man undergoing preoperative evaluation for abdominal aortic aneurysm surgery was noted to have a 3 cm mass in the right adrenal gland with heterogeneous texture but clear margins.
-
For patients in the midst of chemotherapy, there are little data on the most efficacious time to administer influenza vaccine. In a randomized study of 38 patients receiving FEC chemotherapy for adjuvant treatment of breast cancer, it is apparent that vaccination early (on day 4 of a 21-day cycle) provided better antibody response than when administered late in the cycle (day 16).
-
Apixaban could soon join the anticoagulation market; Chinese herbs for flu; chronic medication and discontinuation after hospitalization; and FDA actions.
